3D Visualization of Immune Cell Populations in HIV-Infected Tissues via Clearing, Immunostaining, Confocal, and Light Sheet Fluorescence Microscopy.
Journal
Journal of visualized experiments : JoVE
ISSN: 1940-087X
Titre abrégé: J Vis Exp
Pays: United States
ID NLM: 101313252
Informations de publication
Date de publication:
06 05 2021
06 05 2021
Historique:
entrez:
24
5
2021
pubmed:
25
5
2021
medline:
16
10
2021
Statut:
epublish
Résumé
Human Immunodeficiency Virus (HIV), the causative agent of Acquired Immune Deficiency Syndrome (AIDS), is a major global health concern with nearly 40 million individuals infected worldwide and no widely accessible cure. Despite intensive efforts, a detailed understanding of virus and host cell interactions in tissues during infection and in response to therapy remains incomplete. To address these limitations, water-based tissue clearing techniques CUBIC (Clear, Unobstructed Brain/Body Imaging Cocktails and Computational analysis) and CLARITY (Clear Lipid-exchanged Acrylamide-hybridized Rigid Imaging/Immunostaining/in situ-hybridization-compatible Tissue hYdrogel) are applied to visualize complex virus host-cell interactions in HIV-infected tissues from animal models and humans using confocal and light sheet fluorescence microscopy. Optical sectioning of intact tissues and image analysis allows rapid reconstruction of spatial information contained within whole tissues and quantification of immune cell populations during infection. These methods are applicable to most tissue sources and diverse biological questions, including infectious disease and cancer.
Identifiants
pubmed: 34028448
doi: 10.3791/62441
pmc: PMC10445482
mid: NIHMS1895515
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Video-Audio Media
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : NIDA NIH HHS
ID : DP2 DA051915
Pays : United States
Organisme : NIAID NIH HHS
ID : P01 AI131385
Pays : United States
Organisme : NIAID NIH HHS
ID : P01 AI169609
Pays : United States
Organisme : NIAID NIH HHS
ID : P30 AI036214
Pays : United States
Références
Nat Protoc. 2015 Nov;10(11):1860-1896
pubmed: 26492141
Nat Methods. 2012 Jun 28;9(7):676-82
pubmed: 22743772
Cell. 2014 Nov 6;159(4):911-24
pubmed: 25417165
Cell Res. 2018 Aug;28(8):803-818
pubmed: 29844583
EMBO J. 2005 Jul 6;24(13):2481-9
pubmed: 15920469
Clin Exp Immunol. 2012 Sep;169(3):205-12
pubmed: 22861359
Viruses. 2015 Dec 12;7(12):6590-603
pubmed: 26703714
Elife. 2017 Feb 15;6:
pubmed: 28198699
Breast Cancer Res Treat. 2016 Oct;159(3):575-83
pubmed: 27581127
Curr Protoc Cytom. 2018 Oct;86(1):e38
pubmed: 30005145
Elife. 2019 Oct 28;8:
pubmed: 31657719
Am J Clin Pathol. 2006 Jan;125(1):91-8
pubmed: 16482996
J Histochem Cytochem. 2017 Jan;65(1):5-20
pubmed: 27798289
mBio. 2016 Sep 27;7(5):
pubmed: 27677788
PLoS Pathog. 2017 Feb 2;13(2):e1006099
pubmed: 28152024
Sci Rep. 2016 Apr 12;6:24201
pubmed: 27068335
Nat Med. 2018 Jul;24(7):923-926
pubmed: 29892063
Nat Methods. 2013 Jun;10(6):508-13
pubmed: 23722210